• FirefoxTry Yahoo Finance on Firefox »
  •  Dow Down 1.35% Nasdaq Down 0.34%

    Conatus Pharmaceuticals Inc. (CNAT)

    -NasdaqGM
    1.60 Down 0.05(3.03%) 2:40PM EST - Nasdaq Real Time Price
    Prev Close:1.65
    Open:1.60
    Bid:1.62 x 100
    Ask:1.64 x 500
    1y Target Est:13.00
    Beta:-0.589206
    Earnings Date:Mar 9 - Mar 14 (Est.)
    Day's Range:1.55 - 1.65
    52wk Range:1.40 - 8.46
    Volume:109,628
    Avg Vol (3m):587,394
    Market Cap:31.79M
    P/E (ttm):N/A
    EPS (ttm):-1.34
    Div & Yield:N/A (N/A)
    Quotes delayed, except where indicated otherwise. Currency in USD.

    Comparison

    Symbol% ChgMkt Cap
    CNATDown 3.03%31.79M
    ICPTDown 0.77%2.31B
    GALTDown 0.89%31.88M

    Key Statistics

    Forward P/E (1 yr):N/A
    P/S (ttm):N/A
    Ex-Dividend Date:N/A

    Analysts

    Annual EPS Est (Dec-15) :-1.38
    Quarterly EPS Est (Dec-15) :-0.37
    Mean Recommendation*:1.6
    PEG Ratio (5 yr expected):-1.33

    * (Strong Buy) 1.0 - 5.0 (Sell)

    Analyst Opinion | Estimates

    Business Summary

    Conatus Pharmaceuticals Inc., a biotechnology company, focuses on the development and commercialization of novel medicines to treat liver diseases in the United States. View More
    Your browser doesn't support canvas
    SETTINGS
    Scrolling
    Speed
    Display
    Price
    Submit Feedback